semaglutide equivalent dose to mounjaro Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Compare GLP-1 Options | Ozempic

Evidence includes: Stimulation of endothelial and keratinocyte migration Enhanced blood vessel density in wound healing models Promotion of stem cell differentiation toward repair cell lineages Low molecular weight enabling tissue penetration over long distances Unlike growth factors that bind to extracellular matrix, TB-500s mobility allows systemic distribution to multiple injury sites

Any hormonal shifts are more likely attributable to weight loss itself rather than a direct pharmacological effect of Ozempic

It does not create a permanent safe harbor

This makes sense, as one of the major sites of GLPs effects is on the pancreas

Nutrition guidelines for improved clinical care

Constipation becomes more common